Arcondis Foundation Announces CHF 50,000 Global Grant for Life Sciences Start-up
The Arcondis Foundation has announced that it will be awarding a CHF 50,000 grant to an innovative life sciences start-u…
The Arcondis Foundation has announced that it will be awarding a CHF 50,000 grant to an innovative life sciences start-u…
Entwicklungskandidat AB-1005 (AAV2-GDNF) von allen 11 Patienten über Zeitraum von 18 Monaten gut vertragen / Keine schwe…
PELOBIOTECH GmbH, a leader in the field of biotechnology, announces a strategic partnership with HVD Life Science Vertri…
Das Kunststoff-Zentrum SKZ setzt auf fortschrittliche Prüfverfahren zur Qualitätssicherung von Kunststoffen aus Polyolef…
Last year in October, Mitsubishi Chemical Group’s Growth Garage, in collaboration with partners launched the 3D Printing…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
Weltweit entwickeln Länder politische Strategien für Batterietechnologien oder passen diese an globale Entwicklungen an.…
. New level 1 data from the MAXA Clinical Trial comparing standalone MagnetOs to the gold standard autograft in the ch…
Pentixapharm AG, a developer of innovative radiopharmaceuticals owned by Eckert & Ziegler Strahlen- und Medizintechnik A…
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels in th…